Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Feigenberg

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Clinical Lung Cancer|November 12, 2019
Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative IntentStephanie R Rice, Melissa A L Vyfhuis, Katherine A Scilla, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 27, 2020
<sup>18</sup>F-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitisAustin J Borja, Emily C Hancin, Alexandra D Dreyfuss, et al.
International Journal of Radiation Oncology, Biology, Physics|March 4, 2021
Multiblock Discriminant Analysis of Integrative <sup>18</sup>F-FDG-PET/CT Radiomics for Predicting Circulating Tumor Cells in Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation TherapySang Ho Lee, Gary D Kao, Steven J Feigenberg, et al.
JCO Oncology Practice|May 27, 2020
Management of Lung Cancer During the COVID-19 PandemicAditi P Singh, Abigail T Berman, Melina E Marmarelis, et al.
International Journal of Radiation Oncology, Biology, Physics|November 17, 2018
Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and LymphomaBiniyam G Demissei, Gary Freedman, Steven J Feigenberg, et al.
Breast Cancer Research and Treatment|June 23, 2017
Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysisTejan P Diwanji, Jason K Molitoris, Arpit M Chhabra, et al.
Clinical Lung Cancer|October 20, 2018
Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at DiagnosisStephanie R Rice, Jason K Molitoris, Melissa A L Vyfhuis, et al.
Journal of Thoracic Disease|July 10, 2020
Tumor volume reduction evaluated by cone beam computed tomography during stereotactic body radiotherapy for early stage non-small cell lung cancerDakim K Gaines, Nikhil Yegya-Raman, Sinae Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body RadiotherapyMelissa A Frick, Steven J Feigenberg, Samuel R Jean-Baptiste, et al.
Advances in Radiation Oncology|November 9, 2017
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Whitney M Burrows, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Clinical Lung Cancer|November 12, 2019
Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative IntentStephanie R Rice, Melissa A L Vyfhuis, Katherine A Scilla, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 27, 2020
<sup>18</sup>F-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitisAustin J Borja, Emily C Hancin, Alexandra D Dreyfuss, et al.
International Journal of Radiation Oncology, Biology, Physics|March 4, 2021
Multiblock Discriminant Analysis of Integrative <sup>18</sup>F-FDG-PET/CT Radiomics for Predicting Circulating Tumor Cells in Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation TherapySang Ho Lee, Gary D Kao, Steven J Feigenberg, et al.
JCO Oncology Practice|May 27, 2020
Management of Lung Cancer During the COVID-19 PandemicAditi P Singh, Abigail T Berman, Melina E Marmarelis, et al.
International Journal of Radiation Oncology, Biology, Physics|November 17, 2018
Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and LymphomaBiniyam G Demissei, Gary Freedman, Steven J Feigenberg, et al.
Breast Cancer Research and Treatment|June 23, 2017
Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysisTejan P Diwanji, Jason K Molitoris, Arpit M Chhabra, et al.
Clinical Lung Cancer|October 20, 2018
Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at DiagnosisStephanie R Rice, Jason K Molitoris, Melissa A L Vyfhuis, et al.
Journal of Thoracic Disease|July 10, 2020
Tumor volume reduction evaluated by cone beam computed tomography during stereotactic body radiotherapy for early stage non-small cell lung cancerDakim K Gaines, Nikhil Yegya-Raman, Sinae Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body RadiotherapyMelissa A Frick, Steven J Feigenberg, Samuel R Jean-Baptiste, et al.
Advances in Radiation Oncology|November 9, 2017
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Whitney M Burrows, et al.
Pageof 12